| Name | Title | Contact Details |
|---|---|---|
Tony Meehan |
Chief Financial Officer | Profile |
Timothy Niedrist |
Associate Director of Financial Operations | Profile |
Ajit Roy |
Senior Director of Clinical R&D | Profile |
Helen Libman |
Senior Director, Analytical R&D | Profile |
Vera Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Vera`s lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL), which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. In addition, Vera is evaluating additional diseases where the reduction of autoantibodies by atacicept may prove medically useful, including lupus nephritis, a severe renal manifestation of systemic lupus erythematosus.
Hillsides is a premier provider dedicated to improving the overall well-being and functioning of vulnerable children, youth, and their families.
Abece is a Miami Beach, FL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
I Holland Americas is a Fort Myers, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.